Literature DB >> 25423000

Pulmonary hypertension in sickle cell disease.

Margaret M Hayes1, Amar Vedamurthy, Gautam George, Raed Dweik, Elizabeth S Klings, Roberto F Machado, Mark T Gladwin, Kevin C Wilson, Carey C Thomson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25423000      PMCID： PMC5473670          DOI： 10.1513/AnnalsATS.201408-405CME

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  4 in total

1.  Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.

Authors:  Laura M De Castro; Jude C Jonassaint; Felicia L Graham; Allison Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

2.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

3.  Mortality in adults with sickle cell disease and pulmonary hypertension.

Authors:  Alem Mehari; Mark T Gladwin; Xin Tian; Roberto F Machado; Gregory J Kato
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

4.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245
  4 in total
  11 in total

1.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

Review 2.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

Review 4.  Sickle Cell Disease-Induced Pulmonary Hypertension: A Review of Pathophysiology, Management, and Current Literature.

Authors:  Abu Baker Sheikh; Adeel Nasrullah; Erick Daniel Lopez; Mian Tanveer Ud Din; Shazib Sagheer; Ishan Shah; Nismat Javed; Rahul Shekhar
Journal:  Pulse (Basel)       Date:  2021-09-23

5.  Vascular complications of sickle cell disease.

Authors:  Ashar Usmani; Roberto F Machado
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

6.  Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.

Authors:  Ayla Yalamanoglu; Jeremy W Deuel; Ryan C Hunt; Jin Hyen Baek; Kathryn Hassell; Katie Redinius; David C Irwin; Dominik J Schaer; Paul W Buehler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

7.  Pulmonary hypertension in Nigerian adults with sickle cell anemia.

Authors:  Valentine N Amadi; Michael O Balogun; Norah O Akinola; Rasaaq A Adebayo; Anthony O Akintomide
Journal:  Vasc Health Risk Manag       Date:  2017-05-08

8.  The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension.

Authors:  Hossein Karami; Hadi Darvishi-Khezri; Mehrnoush Kosaryan; Rosetta Akbarzadeh; Mojdeh Dabirian
Journal:  Int Med Case Rep J       Date:  2018-12-17

9.  Pulmonary arterial hypertension associated with hereditary spherocytosis and splenectomy in a patient with a mutation in the BMPR2 gene.

Authors:  Adolfo Baloira; María Bastos; Guillermo Pousada; Diana Valverde
Journal:  Clin Case Rep       Date:  2016-06-30

10.  Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.

Authors:  Sabine Revuz; Evelyne Decullier; Isabelle Ginon; Nicolas Lamblin; Pierre-Yves Hatron; Pierre Kaminsky; Marie-France Carette; Pascal Lacombe; Anne-Claire Simon; Sophie Rivière; Jean-Robert Harlé; Alain Fraisse; Christian Lavigne; Vanessa Leguy-Seguin; Ari Chaouat; Chahera Khouatra; Sophie Dupuis-Girod; Eric Hachulla
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.